. Although 96% of patients with oesophageal candidiasis had a good response to ketoconazole in 3 weeks there was an 80% relapse rate within 3 months.
Diarrhoea might be due to 'gay bowel' organisms, salmonella or opportunistic infections; Kaposi's sarcoma of the gut as a cause of diarrhoea is rare. Cryptosporodium (a common cause of traveller's diarrhoea) was found in up to 50% of cases. No pathology might be found. The most sensitive test was sigmoidoscopy and rectal biopsy (97%): colonoscopy came next (62%) and barium enema last (16%).
Sclerosing cholangitis was commonly found on endoscopic retrograde cholangiopancreatography (ERCP) in patients with right upper quadrant pain, probably due to cryptosporidiosis but CMV might be present.
CMV diarrhoea could be haemorrhagic with marked weight loss. Clinically, abdominal pain with marked rebound tenderness was a characteristic feature. On barium enema the appearances might resemble acute ulcerative colitis including toxic dilatation. In one third, the patient died because of colonic perforation.
The meeting ended with the Presidential Address by Dr Margaret Spittle, the President of the Section, on the 'Oncology of AIDS'. The major oncological problems are posed by Kaposi's sarcoma (KS) and non Hodgkins lymphoma (NHL). Hodgkin's disease, cloacogenic rectal carcinoma and head and neck carcinoma and teratoma can be seen and might be associated with the gay lifestyle or just occur in this age group of patients. The incidence of KS and NHL was 273 and 23 respectively in 1988 and 472 and 52 in 1989.
Kaposi's sarcoma occurs in 40% of homosexuals with AIDS and 1% ofHIV positive haemophiliacs and blood transfusion recipients; the reported incidence seemed to be falling in New York.
On the nose and face, radiotherapy is very useful; a single dose is effective. Oedema of the legs and penis is common in peripheral disease in which 10 doses of 150 cGy is usually effective. In palatal lesions there Role of infection in the aetiopathogenesis of inflammatory rheumatic diseases Keywords: Lyme arthritis; HIV antibodies; Lentivirus arthritis; Reiter's syndrome; reactive arthritis Professor Hans H Peter (University of Freiburg, FRO) (with M Schlesier, J T Epplen) spoke on autoreactive T cells in rheumatic diseases with particular reference to Lyme arthritis. He said that the fact that most rheumatic diseases are associated with MHC gene products and that some show high titres of IgG autoantibodies argues in favour of a central role for T cells during initiation and perpetuation of inflammatory joint diseases. They performed a number oflimiting dilution (LD)culture experiments in order to elucidate the possible role of autoreactive T cells in rheumatic diseases. Autoreactivity in their studies refers to proliferative 'I'cells responses against either autologous antigen presenting cells alone or in the presence of potentially arthritogenic antigens such as type II collagen and U1-snRNP. In addition, could be an unusually aggressive reactive mucositis. Facial oedema also occurs and is resistant to treatment. Radiotherapy, chemotherapy and steroids have been used.
The lungs are best treated by chemotherapy. The CT changes are more often positive than plain chest X-rays. A combination of bleomycin and vincristine can be used but might cause even more immunosuppression. A single nodular mass would respond to radiotherapy. Immunotherapy with interferons is liable to produce undesirable side-effects. It is necessary to differentiate between cosmetic and lifethreatening effects of the disease when planning treatment.
Non Hodgkin's lymphoma could be of High or Intermediate Grade and had a poor prognosis in HIV positive patients. It occurs in the central nervous system, the skin and other sites, and is often poorly differentiated with extranodal involvement. It could be very florid.
Brain lymphoma occurs in 25% of AIDS cases of lymphoma but in only 2% of non-AIDS cases. Diagnosis requires a neurological biopsy but this is often not possible. CT is not diagnostic. In a study, this disease was often terminal and 19 out of 36 were diagnosed at postmortem. In non-AIDS patients 11 out of 14 had a median survival of 5 months but in AIDS patients the prognosis was extremely poor; all were dead within 6 weeks. Treatment was ineffective but radiotherapy to the whole brain with intrathecal methotrexate had been used.
Outside the CNS, using less aggressive chemotherapy, the results were rather better, but it appears that 50% of AIDS patients will die from lymphoma. The UK AIDS Oncology group had been set up to study this problem.
PM Bretland

Editorial Representative
Section of Radiology they investigated T-cell responses against Borrelia burgdorferi (Bb) in some patients with Lyme arthritis (LA). First, they studied frequencies of autoreactive T cells (directed against autologous stimulator cells without exogenous antigen) in blood and synovial fluid of patients with rheumatoid arthritis eRA) and Lyme arthritis (LA). Roughly a lO-fold increase of autoreactive T cells was seen in blood and synovia of RA and LA patients (113000) as compared to blood of healthy volunteers (1120 000). This increase was not considered to be specific for rheumatic diseases since it was also seen in a patient with a viral infection. The majority of the established T-cell lines and clones appeared to be broadly reactive to autologous and allogeneic stimulator cells; only a minority of clones was strictly autoreactive. Most proliferative responses were inhibitable by anti-Dfl/Dl' monoclonal antibodies'.
From one patient (DRw11 homzygous, B27 +) a series of autoreactive T-cell clones were established among which one (UA-S2) proved to be specific from stimulator cells carrying the maternal but not the paternal DRwll haplotype'', Molecular analysis of the DR-beta chain of UA-S2 revealed a microheterogeneity in the 3rd hypervariable region corresponding to a hitherto unknown DRwll.3 variant", The T-cell receptor ofUA-S2 exhibited a new V-alpha element besides a known V-beta 6.7 element".
In another series of experiments they succeeded in establishing from peripheral blood of healthy individuals numerous T-cell lines and clones with specificity for type II collagen-as well as one clone with specificity for U1-snRNP. These findings suggest that T-cell clones with specificity for potentially important autoantigens are present in healthy individuals.
Finally, they found high frequencies of in vivo activated Bb reactive T cells in LA patients (115000) when compared with healthy persons (1/100 000). The precursor frequencies were identical in both groups", Dr Gordon D Harkiss (University of Edinburgh) presented his latest work on immunology oflentivirusinduced arthritis in sheep, an exciting, naturallyoccurring model for human rheumatoid arthritis.
He said that lentiviruses in sheep and goats cause chronic inflammatory lesions in lungs, brains and joints. The slow progression and pathology of the arthritis in these animals bears some resemblance to rheumatoid arthritis in man. The joint changes associated with these viruses appears to begin with infiltration of synovial tissue by macrophage-like cells followed by small lymphocytes and plasma cells. As part of a study of early changes in lentivirus-induced arthritis, synovial fluid samples taken from sheep naturally infected with visna virus were investigated for phenotypic changes, anti-viral antibodies and autoantibodies. Using a range of monoclonal antibodies, it was found that the visna-infected animals had elevated numbers ofT4+ and T8+ mononuclear cells, with the T8+ cells predominating. The numbers of sIg+ cells and T19+ cells (a marker for I'll cells) were also elevated, but to a much lesser extent than T4+ or T8+ cells. Synovial fluids also contained antiviral antibodies and IgG rheumatoid factors as assessed by western blotting and ELISA respectively. Sera from these animals also showed the presence of other autoantibodies. A large proportion of the cells present in synovial fluids had the morphology of macrophages or dendritic cells. Preliminary phenotyping of these cells indicates that a large proportion are CD1 +, MHC class II + and have Ig on their surface, suggesting these cells may be actively taking up immune complexes from the fluid.
Dr Harkiss reported that, in addition to studies in infected sheep, experiments had been carried out in vitro to examine the effects of viral infection on cytokine responses. Such analysis of sheep and goat synovial membrane cells and chondrocytes has shown that these cells produce elevated levels ofIL1{3 mRNA and a cytokine with Il.l-like biological and biochemical properties. These results indicated that infection may lead to chronic dysregulation of ILl synthesis, which in turn may contribute to lymphoproliferation and synovial cell hyperplasia and resorption of cartilage matrix.
Reactive arthritis associated with Yersinia infection was reviewed by Dr J S Hill Gaston (University of Birmingham).
Amongst the infections which are known to trigger reactive arthritis (ReA), those involving Yersinia have Journal of the Royal Society of Medicine Volume 83 October 1990 659 been studied most extensively in Scandinavia. Although cases have been described elsewhere it is likely that Yersinia-related ReA is underdiagnosed in the UK. The triggering organism in ReA is often not isolated by culture and even serological investigation may not be conclusive. This is especially the case when the patient presents with joint inflammation which has already been present for some months, and when gastrointestinal symptoms were too mild to be recalled. Recently, in the course of examining synovial fluid T-cell responses to Yersinia in a large number of patients with inflammatory arthritis, he identified three UK cases of ReA in which there was strong evidence for a primary role for Yersinia.
The pathogenesis of Yersinia-triggered arthropathy is not understood in detail. Previous studies have suggested that the immune response (as judged by production of Yersinia-specific antibodies) is greater and more prolonged in ReA patients than in those patients who do not develop arthritis? The prominence of secretory IgA suggests persistence of the organism in the GI tract. Yersinia-specific antigens, but not viable organisms, have been demonstrated within the joint both in phagocytic cells and as immune complexes-". However, since arthritis develops before the antibody response has fully evolved, it is difficult to implicate humoral immunity in the pathogenesis of at least the initial phase of joint inflammation. Furthermore, since Yersinia is a faculative intracellular organism, a T-cell-mediated response would be expected to play a major part in control of the infection. Paradoxically, when peripheral blood T-cell responses to Yersinia were examined in Finnish ReA patients they were found to be lower than in other post-Yersinia patients!". However, in a later study it was shown that T cells isolated from SF of these same patients mounted vigorous proliferative responses to Yersinia antigens!'.
Dr Hill Gaston stated that he has now undertaken detailed studies of the T-cell response to Yersinia in one of the previously referred to UK cases, a butcher with monoarthritis of the knee. T-cell clones specific for Yersinia were isolated from both synovial fluid and membrane, and showedtwo patterns ofspecificity. Some clones recognizedan antigen present in Y. enterocolitica o:3 but not in Y. pseudotuberculosis, whereas others recognized an antigenfs) common to both species of Yersinia. None of these antigens has yet been characterized; antigens which are common to both Yersinia species might also be shared with other gram-negative organisms, and in his experience polyclonal SF T-cell responses to Yersinia are usually accompanied by responses to Salmonella. One antigen known to be common to many bacteria is the 65kD stress protein'S, T-cell immunoblotting using the patient's polyclonal SF T cells showed a stimulatory fraction ofSDS-solubilized Yersinia at around 65kD. Attempts to determine whether this fraction also stimulates the clones have been frustrated by their inability to recognize fractionated or even unfractionated Yersinia antigens when bound to nitrocellulose, suggesting that critical antigenic epitopes recognized by these clones are not available when the antigen is in the bound form.
It is of interest that this patient, in whom Yersiniaspecific T-cell memory was unequivocally demonstrated, did not have antibodies to Yersinia in either SF or serum when these were tested 6 months after the onset of arthritis. This is unusual but not unknown in Yersinia-related ReA. It could be argued that the T-cell response in the joint merely proves previous exposure to Yersinia, but there was no clinical or serological evidence to implicate any other triggering infection. Thus, although there is no direct evidence to prove arthritogenicity of the T-cell clones isolated from the joint, their prominence in the SF and membrane, the likely presence of Yersinia antigens at this site and the optimal function oflocal antigen presenting cella'" together point to a Yersinia-specific T-cell-mediated response as the major 'engine' of joint inflammation.
However, it should be noted that synovial T-cell responses to Yersinia are not confined to patients with either culture or serological evidence of Yersinia infection, or even to ReA patients; similar responses using SF T cells from both rheumatoid arthritis and spondyloarthropathy patients have been recorded in Birmingham. In the absence of preceding infection these responses are likely indicators of T-cell recognition of antigens/epitopes common to Yersinia and other organisms. A similar argument has been made in respect of North American ReA patients since Yersinia infection, especially with arthritogenic strains, is known to be extremely rare in the US14. It may be profitable to characterize the Yersinia antigens which are being recognized by these noninfected patients since they may point to bacterial antigens which are important in the aetiopathogenesis of T-cell-mediatedjoint inflammation in contexts other than reactive arthritis. However, in this approach it will be important not merely to demonstrate that memory responses can be elicited from T cells infiltrating the joint, but to show that particular T cells are either activated locally or migrate specifically to the joint. In this respect T-cell clones which recognize defined bacterial antigens may be useful reagents for the demonstration in the joint of such antigens, or even of self antigens which can be cross-recognized by bacteria-specific T cells.
Dr Gabrielle Kingsley (Rheumatology Unit, United Medical and Dental Schools of Guy's and St Thomas'
Hospital) spoke on the immunopathogenesis of Chlamydia trachomatis induced Reiter's syndrome.
Reiter's syndrome (RS)l5 is an aseptic inflammatory arthritis which can follow gastrointestinal or urogenital infection. Chlamydia trachomatis is a common precipitating organism; it may be cultured from the genital tract but never from the joint. Most patients carry the class I major histocompatibility complex (MHC) antigen, HLA B27. Despite this, the interaction between arthritis, HLA B27 and C. trachomatis is ill-understood. Immunohistological studies of the RS synovium'" suggest that cell-mediated and not humoral mechanisms are most important in the generation of synovitis. Recent immunofluorescence studies have identified antigenic fragments of chlamydiae in synovial cells l6-l8. However, using the polymerase chain reaction'", chlamydial plasmid DNA was not found in the joint suggesting that the organism was non-viable, Earlier studies'" of RS provided some evidence for a C. trachomatis·specific cell-mediated immune response within the joint. Further studies (unpublished) have confirmed the existence of such a response and the underlying mechanisms have been investigated in more detail.
Synovial lymphocytes from patients with RS, but not those with other inflammatory arthritides, proliferate to chlamydial elementary bodies in vitro. Furthermore, the response is absent or very much less in RS peripheral blood lymphocytes compared with paired cells from the joint. In contrast, the response to the recall antigen tuberculin PPD is higher in the peripheral blood cells than those from the joint. The finding of synovial clamydial-specific T cells 20 suggests that C. trachomatis has a direct role in synovitis. No correlation is seen between the degree of lymphocyte proliferation to C. trachomatis and the titres of antibodies to C. trachomatis detected in samples of serum or synovial fluid taken simultaneously with the cellular samples. Thus, as in Lyme disease'", RS may occur in patients without specific antibodies. Because of the strong link with the MHC class I antigen HLA B27, the MHC restriction of the lymphocyte response to C. trachomatis in RS was analysed. The response to PPD is inhibited only by anti-class II antibodies whereas that to C. trachomatis can be inhibited by both anti-class I and anti-class II monoclonal antibodies indicating a role for class I in C. trachomatis antigen presentation in RS. C. trachomatis responsive T cells were found in both CD4 and CD8 subsets although most of the response lay in the CD4 subset. No consistent increase in gamma-delta T cells was seen in the RS joint compared to paired peripheral blood. Furthermore, in vitro culture of synovial cells with C. trachomatisinduced expansion of gamma-delta T cells in only 2/6 patients.
Further work is required before a clear understanding and thus a specific therapy can be developed. Definition of the T-cell stimulating epitope of C. trachomatis, the role of HLA B27 and the nature of the responder T cell are all relevant.
Heat shock proteins and arthritis was the theme of the talk given by Dr M Billingham (Lilly Research Centre Limited, Windlesham).
Heat shock proteins (HSP) are included in the general category of stress proteins 22, a group of proteins that can be rapidly synthesized when cells undergo physicochemical stresses, of which heat is but one. There are three families of stress proteins based on molecular weights of20 kD, 70 kD and 90 kD, and though some have been isolated and cloned, their functions are not well understood, though the 70 kD family are considered to 'protect' protein and mRNA at times of hyperthermia'S.
The interest of HSP, particularly the 65 kd HSP, to rheumatologists and students of arthritis stems from several recent pieces of information 23 • 24 • A 65 kD HSP is present in many bacteria associated with infectious arthritis and the bacterial molecule has considerable sequence homology with its human counterpart; in fact there is molecular mimicry between the mycobacterial 65 kD and the link protein of articular cartilage. In patients with rheumatoid arthritis, reactivity to the mycobacterial 65 kD HSP frequently exists in that both T·lymphocytes and antibodies recognize the molecule; it is probably the immunodominant antigen ofmycobacteria. The most tantalising evidence for a role ofthe 65 kD HSP in the pathogenesis of arthritis comes from Cohen and his colleagues 24.25 who showed that autoreactive T-lymphocytes which can mediate the model of adjuvant arthritis in the rat, also proliferate in response to this HSP.
Against this cumulative evidence in favour of a role for the 65 kD HSP in the pathogenesis of arthritis, there is evidence that some T-Iymphocyte reactivity in patients with arthritis is to epitopes which are not shared between prokaryotes and eukaryotes'". More tellingly, it has not been possible to induce the model of adjuvant arthritis in the rat by immunizing with the mycobacterial 65 kD HSP27. Admittedly, it is very difficult to establish that any given antigen is linked to the pathogenesis of rheumatoid arthritis, however suggestive the evidence; but for an experimental model such a possibility may be addressed.
Adjuvant arthritis develops in many strains of rat, particularly the inbred Lewis rat, but certain criteria have to be met 28. Mycobacterial, or synthetic adjuvants with arthritogenic properties have to be administered in an oil vehicle by the subcutaneous or intradermal route for successful induction of arthritis, and it is known for bacteria that the peptidoglycan component of the cell wall is essential: in fact the smallest component of the peptidoglycan molecule, muramyl dipeptide, will induce adjuvant arthritis. The model can develop, therefore, in the absence of the 65 kD HSP in the adjuvant inoculum. Furthermore, in a series of experiments using high levels of the mycobacterial 65 kD protein in an oil vehicle, and even combining the HSP with low levels of a synthetic, non-immunogenic adjuvant, CP20961, to mimic the peptidoglycan component of mycobacteria, it was not possible to induce adjuvant arthritis in Lewis rats'". In fact such rats were rendered resistant to further attempts to induce arthritis with arthritogenic levels of mycobacteria, as had been previously described by van Eden and his colleagues's, and by Maries van den Broek et al. 29 for arthritis induced by streptococcal cell walls.
What is clearly emerging from the experimental models of arthritis is that the 65 kD HSP confers resistance to arthritis development 25,27,29 rather than being pathogenic. This is particularly so with models induced by bacterial adjuvants which contain the 65 kD HSP, where pretreatment with as little as 1 p.g of the HSP can prevent the development of arthritis'". Other models of arthritis, such as those induced by pristane, CP20961 (a synthetic adjuvant) and type II collagen are also inhibited by pretreatment with the 65 kD HSp28, but this inhibition is not so marked as that seen in the bacterially induced models.
HSP thus provide considerable interest in the rheumatology arena. Their role in the pathogenesis of human rheumatoid arthritis has not yet been established, though it now seems unlikely that the 65 kD HSP has a pathogenic role in adjuvant arthritis. What is perhaps more interesting and worthy of further investigation is the way HSP induce resistance to arthritis; this may be shared by both the models and the human disease.
HIV infection and arthritis was presented by
Dr A Keat ( to rheumatologists at these centres between October 1985 and April 1989. During this time several reports have drawn attention to rheumatic lesions occurring in HIV-infected individuals including Reiter's syndromes", a Sjogren's-like syndrorne'", infective arthritis, myositis and myopathy, vasculitis and the occurrence of various auto-antibodies.
Data were presented on 123 individuals'". Of these, 119 were homosexual men and 36 had evidence of inflammatory arthritis at presentation. Eleven of these 36 patients were not known to be HIV-positive at the time of presentation. The commonest joints involved were knee, ankle and MTP; arthritis was usually mono-or oligoarticular though eight had polyarticular disease. Tests for rheumatoid factor were negative in all individuals and none had any definite radiographic abnormalities at presentation. HLA tissue typing was only possible in four individuals all of whom were HLA-B27 positive.
Synovial biopsies were taken in three cases each revealing non-specific synovitis. Evidence of the presence of HIV joint material was sought using conventional virological techniques and in situ hybridization. Synovial fluid from one patient produced a typical cytopathic effect in cell culture with positive immunofluorescence staining for HIV and production of reverse transcriptase. Two other samples produced typical cytopathic effect only. Attempts to localize virus using in situ hybridizatiorrf revealed the presence of viral DNA in 4-25% oflarge mononuclear cells, presumed to be dendritic cells, isolated from both peripheral blood and synovial fluid and in occasional lymphocytes from peripheral blood (0.1%). No infected macrophages were seen.
Twelve of the 36 individuals with arthritis had psoriasis. In seven it arose do novo in association with the arthritis. In three, lesions were extremely severe and extensive including solar guttate psoriasis in one individual and typical keratoderma blennorrhagica in two.
In two patients with typical reactive arthritis serological evidence of recent Yersinia infection (one Y. enterocolitica, the other Y. pseudotuberculosis) was detected. One individual had persistent diarrhoea with campylobacter jejuni isolated from stools and five had non-specific urethritis.
No correlation was found between the development of arthritis and the stage of disease or severity of immune suppression. During a 10-month follow-up period six progressed to AIDS and three died. In 15 patients arthritis has persisted for more than 12 months but in eight full recovery after a mean period of 7 months have been observed. Others have been lost to follow-up.
Seven patients had infective bone and joint lesions, including pre-patellar bursitis, osteomyelitis due to atypical mycobacterial infection and histoplasma capsulatium infection, staphylococcal, gonococcal and tuberculous arthritis and a deep soft tissue abscess restricting hip movement.
Whilst detailed epidermiological studies are awaited it is clear that synovitis does occur in the presence of HIV infection even in the presence of severe CD4 cell depletion. Both aseptic and septic joint lesions occur and in a high proportion of cases patients present before HIV infection has been recognized. The presence of HIV in both lymphocytes and antigen presenting cells within the joint raises important pathogenetic implications.
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